Biosimilars Market Overview:
A New Market Study, Titled “Biosimilars Market Upcoming Trends, Growth Drivers and Challenges” has been featured on fusionmarketresearch.
The Biosimilars Market report is latest report published by Fusion Market Research which provides comprehensive information, overview of the demands and describe Impact of Covid-19 on the market during the forecast period 2022–2030.
Get Free Sample Report @ https://www.fusionmarketresearch.com/sample_request/Biosimilars-Market-Global-Outlook-and-Forecast-2023-2029/885819
Fusion Market Research (FMR) has surveyed the Biosimilars manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
This report contains market size and forecasts of Biosimilars in global, including the following market information:
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biosimilars sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Novartis
Biocon
Biogen
Fresenius Kabi AG
Boehringer Ingelheim
Merck KgaA
Mylan
Eli Lilly
Teva Pharmaceutical
Dr. Reddy’s Laboratories
Amgen
Celltrion
Samsung Biologics
Roche
Probiomed
Apotex
Chong Kun Dang
JCR Pharmaceuticals
Gan & Lee Pharmaceuticals
Gedeon Richter
Biocad
Coherus Bioscience
Stada Arzneimittel AG
Total Market by Segment:
Global Biosimilars Market Segment Percentages, by Type, 2022 (%)
Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
Recombinant Glycosylated Proteins
Global Biosimilars Market Segment Percentages, by Application, 2022 (%)
Oncology
Blood Disorders
Growth Hormonal Deficiency
Chronic and Autoimmune Disorders
Others
Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America (Brazil, Argentina and Colombia etc.)
Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)
Drop an Enquiry @ https://www.fusionmarketresearch.com/enquiry.php/Biosimilars-Market-Global-Outlook-and-Forecast-2023-2029/885819
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Biosimilars Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biosimilars Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biosimilars Overall Market Size
2.1 Global Biosimilars Market Size: 2022 VS 2029
2.2 Global Biosimilars Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Biosimilars Sales: 2018-2029
…
7 Manufacturers and Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Biosimilars Major Product Offerings
7.1.4 Pfizer Biosimilars Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Biosimilars Major Product Offerings
7.2.4 Novartis Biosimilars Sales and Revenue in Global (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Biocon
7.3.1 Biocon Company Summary
7.3.2 Biocon Business Overview
7.3.3 Biocon Biosimilars Major Product Offerings
7.3.4 Biocon Biosimilars Sales and Revenue in Global (2018-2023)
7.3.5 Biocon Key News & Latest Developments
7.4 Biogen
7.4.1 Biogen Company Summary
7.4.2 Biogen Business Overview
7.4.3 Biogen Biosimilars Major Product Offerings
7.4.4 Biogen Biosimilars Sales and Revenue in Global (2018-2023)
7.4.5 Biogen Key News & Latest Developments
7.5 Fresenius Kabi AG
7.5.1 Fresenius Kabi AG Company Summary
7.5.2 Fresenius Kabi AG Business Overview
7.5.3 Fresenius Kabi AG Biosimilars Major Product Offerings
7.5.4 Fresenius Kabi AG Biosimilars Sales and Revenue in Global (2018-2023)
7.5.5 Fresenius Kabi AG Key News & Latest Developments
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Company Summary
7.6.2 Boehringer Ingelheim Business Overview
7.6.3 Boehringer Ingelheim Biosimilars Major Product Offerings
7.6.4 Boehringer Ingelheim Biosimilars Sales and Revenue in Global (2018-2023)
7.6.5 Boehringer Ingelheim Key News & Latest Developments
7.7 Merck KgaA
7.7.1 Merck KgaA Company Summary
7.7.2 Merck KgaA Business Overview
7.7.3 Merck KgaA Biosimilars Major Product Offerings
7.7.4 Merck KgaA Biosimilars Sales and Revenue in Global (2018-2023)
7.7.5 Merck KgaA Key News & Latest Developments
7.8 Mylan
7.8.1 Mylan Company Summary
7.8.2 Mylan Business Overview
7.8.3 Mylan Biosimilars Major Product Offerings
7.8.4 Mylan Biosimilars Sales and Revenue in Global (2018-2023)
7.8.5 Mylan Key News & Latest Developments
7.9 Eli Lilly
7.9.1 Eli Lilly Company Summary
7.9.2 Eli Lilly Business Overview
7.9.3 Eli Lilly Biosimilars Major Product Offerings
7.9.4 Eli Lilly Biosimilars Sales and Revenue in Global (2018-2023)
7.9.5 Eli Lilly Key News & Latest Developments
7.10 Teva Pharmaceutical
7.10.1 Teva Pharmaceutical Company Summary
7.10.2 Teva Pharmaceutical Business Overview
7.10.3 Teva Pharmaceutical Biosimilars Major Product Offerings
7.10.4 Teva Pharmaceutical Biosimilars Sales and Revenue in Global (2018-2023)
7.10.5 Teva Pharmaceutical Key News & Latest Developments
7.11 Dr. Reddy’s Laboratories
7.11.1 Dr. Reddy’s Laboratories Company Summary
7.11.2 Dr. Reddy’s Laboratories Biosimilars Business Overview
7.11.3 Dr. Reddy’s Laboratories Biosimilars Major Product Offerings
7.11.4 Dr. Reddy’s Laboratories Biosimilars Sales and Revenue in Global (2018-2023)
7.11.5 Dr. Reddy’s Laboratories Key News & Latest Developments
7.12 Amgen
7.12.1 Amgen Company Summary
7.12.2 Amgen Biosimilars Business Overview
7.12.3 Amgen Biosimilars Major Product Offerings
7.12.4 Amgen Biosimilars Sales and Revenue in Global (2018-2023)
7.12.5 Amgen Key News & Latest Developments
7.13 Celltrion
7.13.1 Celltrion Company Summary
7.13.2 Celltrion Biosimilars Business Overview
7.13.3 Celltrion Biosimilars Major Product Offerings
7.13.4 Celltrion Biosimilars Sales and Revenue in Global (2018-2023)
7.13.5 Celltrion Key News & Latest Developments
7.14 Samsung Biologics
7.14.1 Samsung Biologics Company Summary
7.14.2 Samsung Biologics Business Overview
7.14.3 Samsung Biologics Biosimilars Major Product Offerings
7.14.4 Samsung Biologics Biosimilars Sales and Revenue in Global (2018-2023)
7.14.5 Samsung Biologics Key News & Latest Developments
7.15 Roche
7.15.1 Roche Company Summary
7.15.2 Roche Business Overview
7.15.3 Roche Biosimilars Major Product Offerings
7.15.4 Roche Biosimilars Sales and Revenue in Global (2018-2023)
7.15.5 Roche Key News & Latest Developments
7.16 Probiomed
7.16.1 Probiomed Company Summary
7.16.2 Probiomed Business Overview
7.16.3 Probiomed Biosimilars Major Product Offerings
7.16.4 Probiomed Biosimilars Sales and Revenue in Global (2018-2023)
7.16.5 Probiomed Key News & Latest Developments
7.17 Apotex
7.17.1 Apotex Company Summary
7.17.2 Apotex Business Overview
7.17.3 Apotex Biosimilars Major Product Offerings
7.17.4 Apotex Biosimilars Sales and Revenue in Global (2018-2023)
7.17.5 Apotex Key News & Latest Developments
7.18 Chong Kun Dang
7.18.1 Chong Kun Dang Company Summary
7.18.2 Chong Kun Dang Business Overview
7.18.3 Chong Kun Dang Biosimilars Major Product Offerings
7.18.4 Chong Kun Dang Biosimilars Sales and Revenue in Global (2018-2023)
7.18.5 Chong Kun Dang Key News & Latest Developments
7.19 JCR Pharmaceuticals
7.19.1 JCR Pharmaceuticals Company Summary
7.19.2 JCR Pharmaceuticals Business Overview
7.19.3 JCR Pharmaceuticals Biosimilars Major Product Offerings
7.19.4 JCR Pharmaceuticals Biosimilars Sales and Revenue in Global (2018-2023)
7.19.5 JCR Pharmaceuticals Key News & Latest Developments
7.20 Gan & Lee Pharmaceuticals
7.20.1 Gan & Lee Pharmaceuticals Company Summary
7.20.2 Gan & Lee Pharmaceuticals Business Overview
7.20.3 Gan & Lee Pharmaceuticals Biosimilars Major Product Offerings
7.20.4 Gan & Lee Pharmaceuticals Biosimilars Sales and Revenue in Global (2018-2023)
7.20.5 Gan & Lee Pharmaceuticals Key News & Latest Developments
7.21 Gedeon Richter
7.21.1 Gedeon Richter Company Summary
7.21.2 Gedeon Richter Business Overview
7.21.3 Gedeon Richter Biosimilars Major Product Offerings
7.21.4 Gedeon Richter Biosimilars Sales and Revenue in Global (2018-2023)
7.21.5 Gedeon Richter Key News & Latest Developments
7.22 Biocad
7.22.1 Biocad Company Summary
7.22.2 Biocad Business Overview
7.22.3 Biocad Biosimilars Major Product Offerings
7.22.4 Biocad Biosimilars Sales and Revenue in Global (2018-2023)
7.22.5 Biocad Key News & Latest Developments
7.23 Coherus Bioscience
7.23.1 Coherus Bioscience Company Summary
7.23.2 Coherus Bioscience Business Overview
7.23.3 Coherus Bioscience Biosimilars Major Product Offerings
7.23.4 Coherus Bioscience Biosimilars Sales and Revenue in Global (2018-2023)
7.23.5 Coherus Bioscience Key News & Latest Developments
7.24 Stada Arzneimittel AG
7.24.1 Stada Arzneimittel AG Company Summary
7.24.2 Stada Arzneimittel AG Business Overview
7.24.3 Stada Arzneimittel AG Biosimilars Major Product Offerings
7.24.4 Stada Arzneimittel AG Biosimilars Sales and Revenue in Global (2018-2023)
7.24.5 Stada Arzneimittel AG Key News & Latest Developments
Continue…
ABOUT US:
Fusion Market Research is one of the largest collections of market research reports from numerous publishers. We have a team of industry specialists providing unbiased insights on reports to best meet the requirements of our clients. We offer a comprehensive collection of competitive market research reports from a number of global leaders across industry segments.
CONTACT US
Phone:
+ (210) 775-2636 (USA)
+ (91) 853 060 7487
Related Posts – Coffee Grounds Market Size, Trends, Share and Forecast to 2030